Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,400.00p
   
  • Change Today:
      50.00p
  • 52 Week High: 4,750.00
  • 52 Week Low: 2,200.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 16,776
  • Market Cap: £125.27m
  • Beta: 0.00

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Dec-24 Interim 6.73 5.05 72.27p 70.00p

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 10.31 8.23 139.41p 29.8 1.4 +22% 88.00p 2.1%
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%
30-Jun-24 13.61 10.60 155.12p 28.4 n/a -3% 155.00p 3.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 13.50 10.10 151.50p 15.8 n/a -2% 155.00p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 29.77 23.42 27.25 0.56

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Bioventix Market Data

Currency UK Pounds
Share Price 2,400.00p
Change Today 50.00p
% Change 2.13 %
52 Week High 4,750.00
52 Week Low 2,200.00
Volume 16,776
Shares Issued 5.22m
Market Cap £125.27m
Beta 0.00

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.85% below the market average38.85% below the market average38.85% below the market average38.85% below the market average38.85% below the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Price Trend
72.7% below the market average72.7% below the market average72.7% below the market average72.7% below the market average72.7% below the market average
34.69% below the sector average34.69% below the sector average34.69% below the sector average34.69% below the sector average34.69% below the sector average
Income
40.81% above the market average40.81% above the market average40.81% above the market average40.81% above the market average40.81% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
26% below the market average26% below the market average26% below the market average26% below the market average26% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 07-Apr-2025

Time Volume / Share Price
17:06 250 @ 2,400.00p
16:45 100 @ 2,400.00p
16:11 120 @ 2,441.00p
15:33 250 @ 2,500.00p
15:29 500 @ 2,490.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page